PV prevalence for BRCA1/2 was 7.8% and 9.0% for Caucasian and African American (AA) women, respectively, and when expanding testing to include a panel of 21 BC susceptibility genes, PV prevalence increased to 14.0% and 14.6%, respectively5. Here, BRCA1 is linked to acquired polycythemia vera.